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ABSTRACT
Background : As in any vascular access the size of guiding catheter is an operator
preference. Although multiple studies have showed that the use of 5-Fr and 6-Fr guiding
catheters for transradial coronary intervention (TCI) have similar vascular safety profiles,
the data comparing the 5-Fr vs 6-Fr guiding catheters for TCI in terms of fluoroscopy
time, procedure time and contrast amount in the setting of acute coronary syndrome
(ACS) is limited. We conducted this study to compare the use of 5-Fr versus 6-Fr guiding
catheters for TCI in the settings of ACS.
Method: Our study is a single center, retrospective cohort study designed to compare
the use of 5-Fr versus 6-Fr guiding catheters for TCI in the setting of ACS. In the
period between July 2014 and July 2015, all patients who had previously undergone
percutaneous coronary intervention (PCI) with having at least one stent being placed,
utilizing a radial access, and using a 5-Fr or 6-Fr guiding catheter were included. No
exclusion criteria were applied. The study was approved by Marshall University’s
institutional review board.
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Results : There was a significant reduction in the volume of contrast medium used with
the 5-Fr group compared to the 6-Fr group (130.66 +/- 3.46 ml vs. 166.25 +/- 10.05 ml in
the 5-Fr and 6-Fr groups, respectively; p < 0.001), fluoroscopy time (12.62 +/- 0.50 min
vs. 16.61 +/- 1.28 min in the 5-Fr and 6-Fr groups, respectively; p = 0.005) and there was
also significant reduction in the procedure time in the 5-Fr group (38.74 +/- 1.27 min vs.
46.03 +/- 2.86 min in the 5-Fr and 6-Fr groups, respectively; p = 0.023).
Conclusion: TCI in the settings of ACS is safe and feasible, whether using 5-Fr or 6-Fr
catheters. Our study concluded that using 5-Fr catheters for TCI could be preferred for
patients presenting with ACS due to lower amount of contrast medium used and less
fluoroscopy and procedure time. However, this is a single center retrospective study, so
we suggest that large randomized controlled studies are needed.

KEYWORDS

Radial, PCI, Catherization, ACS, Contrast, Fluoroscopy, 5-Fr, 6-Fr, Catheter

BACKGROUND
The radial approach offers multiple advantages for
vascular access. The superficial location of the vessel
makes access and hemostasis straightforward, with
a very low incidence of vascular complications. In
most individuals, the presence of dual circulation to
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the hand via the ulnar artery, which communicates
with the radial artery via a palmar arch, minimizes
the risk of ischemic complications should radial
occlusion occur. The recommended entry point into
the radial artery is not close to the nerve and vein,
thus limiting the possibility of injury. Because there
is no need to lie supine afterward, patient comfort
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and time to ambulation are dramatically improved,
and with earlier ambulation times and lower vascular
complication rates, hospital costs may be reduced.
Dr. Campeau in 1989 reported the first successful
diagnostic transradial coronary catheterization.1 In
later years, it was followed by the first successful
transradial coronary intervention, which was
conducted by Kiemeneij in 1993.2 Subsequently, the
radial artery has been proven as the preferred access
site for coronary intervention; its many advantages
include: lower rates of access site complications,
shorter hospital stays, and better patient satisfaction
in comparison with transfemoral access.3-5 The RIVAL
trial, which compared radial versus femoral access
for coronary intervention in patients presenting with
acute coronary syndromes, showed that radial access
in ACS settings was associated significant reduction
in major vascular access site complications compared
to femoral access.6
The disadvantages of radial artery access are the
small caliber of the artery that can accommodate
only smaller sheath and catheter systems (up to
6-Fr in most patients, and occasionally 7-Fr in a
large individual); “slender” sheath systems minimize
the outer diameter required to accommodate the
corresponding catheters. Radial artery spasm may
limit the ability to manipulate catheters and can be
very painful.
One of the main complications of radial artery
access approach is radial artery occlusion (RAO).
The incidence of RAO varies widely in literature with
some studies reporting low incidence (~1%) and
some studies reporting almost one third of patients
will have RAO. The high variation in the incidence
is most likely because RAO is overlooked as most of
the operators do not check for radial artery patency
before discharge.7
Although multiple studies have shown that the use
of 5-Fr versus 6-Fr guiding catheters for TCI have
similar vascular safety profiles,8,9 the data comparing
the 5-Fr vs 6-Fr guiding catheters for TCI in terms
of fluoroscopy time, procedure time and contrast
amount in the setting of ACS is limited.
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METHODS
Study design and patient population
Our study is a single center, retrospective cohort
study designed to compare the use of 5-Fr versus
6-Fr guiding catheters for TCI in the setting of ACS.
In the period between July 2014 and July 2015, all
patients who had previously undergone PCI with
having at least one stent being placed, utilizing
a radial access, and using a 5-Fr or 6-Fr guiding
catheter were included. No exclusion criteria were
applied. The study was approved by Marshall
University’s institutional review board.
P rocedure description
Transradial catheterization was performed via the
right or left radial artery as per operator preference.
A 5-Fr or 6-Fr guiding catheter was then used. Radial
mix including heparin, nitroglycerin and verapamil
was administered to prevent arterial spasm and
thrombosis. At the end of the procedure a transradial
band was applied to achieve hemostasis.
Endpoints
The primary study endpoint was the contrast
amount, fluoroscopy time and procedure time which
is defined as the interval between administration of
local anesthesia for obtaining vascular access and
removal of the last catheter.
Data collection
Demographics and clinical characteristics of patients
along with the various endpoints of the study were
retrospectively collected from medical records as
detailed in Table 1.
Statistical analysis
Categorical variables were presented as percentages
and compared using the T score test as appropriate.
Contrast volume administered during the procedure,
fluoroscopy time and total procedure time are
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TABLE 1: Patients demographics and characteristics

continuous variables and they were presented
as mean ± SD. All analyses were done using SPSS
version 24.0. statistical software. Differences were
assumed statistically significant when P value <0.05.
RESULTS
From July 2014 through July 2015, a total of
267 transradial catheterization procedures were
performed at our center. The 5-Fr guiding catheter
was used in 203 patients while the 6-Fr guiding
catheter was used in 64 patients. The mean patient
age of the overall sample was 65.1 ± 11.8 years;
34.5% of which were females and 65.5% were males.
Presentation as ST-segment elevation myocardial
infraction (STEMI) was seen in 5.2%, non-STsegment elevation myocardial infarction (NSTEMI) in
41.9%, and unstable angina (UA) in 52.8%. The two
groups’ characteristics are expressed in Table I. There
was a significant reduction in the volume of contrast
medium used with the 5-Fr group compared to the
6-Fr group (130.66 +/- 3.46 ml vs. 166.25 +/- 10.05 ml
in the 5-Fr and 6-Fr groups, respectively; p < 0.001),
fluoroscopy time (12.62 +/- 0.50 min vs. 16.61 +/1.28 min in the 5-Fr and 6-Fr groups, respectively; p
= 0.005) and, procedure time in the 5-Fr group (38.74
+/- 1.27 min vs. 46.03 +/- 2.86 min in the 5-Fr and
6-Fr groups, respectively; p = 0.023).
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DISCUSSION
Procedural technical variables like artery-to-sheath
ratio, heparin use, and duration of compression
have been reported to affect the incidence of RAO.
Multiple prospective trials showed smaller sheath
sizes associated with reducing RAO.10
Although the transradial access has become the
preferred access site for coronary intervention for
many interventional cardiologists, there also was
no conclusive data or consensus among experts on
the optimal sheath size that is required during the
procedure. Some interventional cardiologists favor
the 5-Fr system to limit the risk of radial artery spasm
or access site bleeding. On the contrary, there are
other operators who prefer the 6-Fr system, since
it permits the use of larger devices, and/or larger
catheter size that offers better catheter mobility
techniques.11
Numerous single-center studies were conducted
to compare the use of 6-Fr catheters to the 5-Fr
systems8,9 with subsequent meta-analysis12
performed and published in 2015. The results of
that concluded that both the 5-Fr and 6-Fr systems
have excellent safety profiles. The use of 5-Fr
guide catheters however was associated with a
lower contrast medium administration, and lower
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bleedings without compromising procedural success
or procedure length.12
Hamon et al had reported favorable results using
a 5-Fr guiding catheter in patients with ACS.13
This study, however, focused on the results
of the procedural success rate and access site
complications. This did not directly correlate the
5-Fr with 6-Fr guide catheters in regard to the total
amount of contrast as well as complete fluoroscopy
time.
Few of the studies that compared 5-Fr vs 6-Fr guiding
catheters for TCI in terms of fluoroscopy time,
procedure time and contrast amount have included
ACS patients among their populations,8,9 Yet, the
number of ACS patients in these studies was very
low. Our study has larger number of ACS patients
and is the first to our knowledge to compare the use
of 5-Fr versus 6-Fr guiding catheters for TCI in terms
of fluoroscopy time, procedure time and contrast
amount only in the setting of ACS. We conclude that
even during ACS, the use of 5-Fr guide catheters was
associated with a significant reduction in the amount
of contrast medium administered, fluoroscopy
time, without increasing the overall procedure time.
Given the excellent outcomes with the 5-Fr system
throughout the elective and/or emergent coronary
intervention, we believe this potentially could be the
go-to choice for interventional cardiologists.
There are certain subsets of patients that may gain
the highest benefits from using 5-Fr guide catheters.
For instance, this could be particularly useful in
female patients undergoing coronary intervention,
as women tend to have on average a smaller radial
artery compared to men, which results in a higher
likelihood of trauma to the vessel wall when using
a 6-Fr catheter compared to 5-Fr guide catheter.14,15
Another subgroup of patients that may derive
greater benefits from using smaller guide catheters
are patients with chronic kidney disease who present
with ACS as our study showed lower contrast amount
used with 5-Fr catheters compared to 6-Fr catheters.
Since it is well known that a lower contrast medium
is associated with a lower risk of contrast-induced
nephropathy (CIN), consequently, the use of 5-Fr
catheters ideally can result in a lower chance of acute
renal failure in patients with chronic kidney disease
or when recurring procedure is warranted.
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Our findings have demonstrated that the use of 5-Fr
catheters system in TCI has led to a lower contrast
amount despite being used during ACS (NSTEMI,
STEMI, and UA), in comparison to 6-Fr system. In
addition to the many other benefits for using a 5-Fr
sheath and guiding catheter, it has a favorable effect
on vascular access complications.
Based on our study results we correspond with the
previous conclusions indicating that a learning curve
is crucial for a successful round of the 5-Fr strategies.
In addition to the constant advancements and
evolution of the guiding catheters, it is vital for all
interventional cardiologists to familiarize themselves
with the various shapes and sizes of guiding
catheters.
There is no dispute that using 5-Fr guiding catheters
for TCI still have some limitations especially when
more intricate interventions are needed like PCI
to the left main coronary artery, or when kissing
balloon strategy is warranted for bifurcation lesions
(in this case the 5-Fr catheter size may not be
feasible, and a larger catheter size will additionally
be required). Another disadvantage of using 5-Fr
catheters is the lack of backup support of the
catheter, which may not hold enough for certain
coronary intervention procedures.
We concur with Alberto Polimeni et al’s conclusion
that one significant advantage of the 5-Fr system is
that it can be engaged deeply and selectively into
coronary arteries, permitting an influx in the rate of
successful stent implantation in a complex coronary
anatomy.12
LIMITATIONS
This study is designed retrospectively, so it was
not possible to ascertain the post procedure
complications; however, there were no major
complications mentioned in the charts. Furthermore,
due to the retrospective design of this study it was
not possible to look for and ascertain various factors
that led to a sample size discrepancy between
the 5-Fr and 6-Fr groups which might affect our
results. These factors include operator preference/
experience, patient factors such as BMI, age, gender,
prior history of catheter use in same patient,
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anticipation of device use in high risk cases, setting/
availability etc.
CONCLUSION
TCI in the settings of ACS is safe and feasible, whether
using 5-Fr or 6-Fr catheters. Our study concluded that
using 5-Fr catheters for TCI could be preferred for
patients presenting with ACS due to lower amount
of contrast medium used and less fluoroscopy and
procedure time. However, this is a single center
retrospective study so we suggest that large
randomized controlled studies are needed.
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